Secured Financed Services (SFS) for Online Capital Funding – Medtech, Pharma, Biotech, and Life Sciences
Medical Funding Professionals, LLC (MFP) announced today that it launched secured financed services (SFS) for medtech, pharma, biotech, and life sciences companies seeking to raise capital online.
Who should be interested?
- All medtech, pharma, biotech, and life sciences companies seeking to raise capital and needing to preserve cash
- All service providers servicing these companies
What is Secured Financed Services™ (SFS)?
SFS™ is an invitation only, capital planning, secured project finance model derived from a combination of financing strategies. SFS has three key pillars:
- Cost-effectively raise capital concurrently from sophisticated investors and a broader more diverse pool of investors – namely investment dollars from retail investors
- Defer up to 47% of the fixed costs to build a company-branded online capital raising platform at a time when the need for cash is most critical
- Settle accounts as cash becomes available from the capital raised
SFS is new and revolutionary in the so-called online, crowd-, or democratized capital funding industry.
How does SFS work?
SFS is available to the best-of-the-best pharma, biotech, and life sciences companies by invitation after a prequalification period. To qualify, companies and their leadership must agree to and pass checks: credit, suitability, probability, background and CPVS™ (discussed below). These checks are required for online capital fundraising. Once invited, based on our underwriting, we defer up to 18 months up to 47% of the up-front costs required to build a successful company-branded online capital fundraising platform.
These costs include registered investment advisor (RIA), corporate finance (CorpFin), legal restructuring and regulatory compliance, transfer agent, online platform and media marketing. We take a security interest in a portion of the future capital raised to repay the deferred costs and other assets and capital interests.
All deferred costs are due and payable at the end of the deferral period. Going forward, the company has a free and clear online company-branded funding platform that it can leverage into perpetuity for future online capital raises.
“In the 90s, everyone raced to build a website to market and sell goods and services, now with the JOBS Act , the play is to take those websites to the next level and build branded platforms to market and sell their stock, notes, bonds and other securities, but they need a cost-effective strategy to do so – SFS,” said Stephen Brock, MFP Founder and CEO.
Is SFS right for my company?
SFS is right for your company if you need to raise capital and you can answer “yes” to any of the following questions:
- Does my company need to preserve cash?
- Can my company benefit from an online capital raising platform that I can use to raise capital in perpetuity (new product launch, FDA approval, successful clinical trials, award of government contract and other milestones)?
- Do I want to retain control of my company after raising up to $75M?
- Do I want to work with the industry leaders in online capital funding for medtech, pharma, biotech, and life sciences companies?
What is CPVS™?
Capital Planning Valuation Strategy™ (CPVS™) is our proprietary 6-week process designed to help founders understand how to retain control of their companies after raising up to $75M in any number or types of financings, identify existing shareholders committed to additional funding for working capital and capital expenses, and build a blueprint for a successful online capital raise supported by these fundamentals:
- Pro Forma Cap Table
- Fair Valuation Estimate
- Pre- and Post-Money Valuations
- Selling Shareholders Analysis
- Capital and Cash Flow Projection
- Deal Comps Analysis
- Historical Funding Data
- Taped Video Recording
Together with founders, we use CPVS™ to determine if online capital funding is a good fit for your company. Before we extend an invitation to SFS, in addition to other checks, your company must complete CPVS™.
What if my company is not quite ready for SFS?
We provide tiered services for companies that already know, going in, they are not quite ready for SFS.
- CPVS™
- CPVS Plus™ (CPVS™ plus ongoing RIA and CorpFin cap table advice, legal restructuring, and preliminary, stepping-stone capital raise in preparation for an online offering using SFS financing)
If you’d like to learn more about our new and revolutionary SFS model and how we can help you achieve your capital raising goals for your medtech, pharma, biotech, or life science company, you can schedule a time with me here by clicking on this link “Schedule A Call” and choosing a specific date and time that works for you.
Contact
Stephen Brock, CEO
- Phone: (775) 772-3684
- Email: stephen.brock@medicalfundingpro.com
- Website: www.medicalfundingpro.com
Disclaimer:
Medical Funding Professionals (MFP) is a registered investment advisor located in Nevada. MFP and its representatives are in compliance with the current filing requirements imposed upon registered investment advisors by those jurisdictions in which MFP maintains clients. MFP may only transact business in those states in which it is registered or qualifies for an exemption or exclusion from registration requirements. None of the information contained in this communication constitutes an offer (or solicitation of an offer) to buy or sell any securities, to make any investment, or to participate in any particular investment, offering, or trading strategy. The information and materials provided herein, whether or not provided on MFP emails, website/webpages, on third party websites, in marketing materials, newsletters or any form of publication are provided for general information and educational purposes, and do not constitute legal, tax or investment advice. Capital Planning Valuation Strategy, CPVS, CPVS Plus, Secured Financed Services and SFS are trademarks of Medical Funding Professionals, LLC.
